Rituximab-CHOP and Central Nervous System Prophylaxis Using Intrathecal Methotrexate in Primary Breast Diffuse Large B-Cell Lymphoma: A Prospective, Multicenter, Single-Arm Phase II Study

被引:0
|
作者
Yhim, Ho-Young [1 ]
Suh, Cheolwon [2 ]
Kim, Seok Jin [3 ]
Yang, Deok-Hwan [4 ]
Eom, Hyeon-Seok [5 ]
Kim, Kyoung Ha [6 ]
Park, Yong [7 ]
Kim, Jin Seok [8 ]
Kim, Hyo Jung [9 ]
Yoon, Dok Hyun [2 ]
Kim, Won Seog [3 ]
Kwak, Jae-Yong [1 ]
机构
[1] Chonbuk Natl Univ, Dept Internal Med, Med Sch, Jeonju, South Korea
[2] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea
[4] Chonnam Natl Univ Hwasun Hosp, Dept Internal Med, Hwasun, South Korea
[5] Natl Canc Ctr, Ctr Hematol Malignancies, Goyang, South Korea
[6] Soonchunhyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[7] Korea Univ, Anam Hosp, Dept Internal Med, Sch Med, Seoul, South Korea
[8] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[9] Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea
关键词
D O I
10.1182/blood-2019-122631
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4076
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial
    Delarue, Richard
    Tilly, Herve
    Mounier, Nicolas
    Petrella, Tony
    Salles, Gilles
    Thieblemont, Catherine
    Bologna, Serge
    Ghesquieres, Herve
    Hacini, Maya
    Fruchart, Christophe
    Ysebaert, Loic
    Ferme, Christophe
    Casasnovas, Olivier
    Van Hoof, Achiel
    Thyss, Antoine
    Delmer, Alain
    Fitoussi, Olivier
    Molina, Thierry Jo
    Haioun, Corinne
    Bosly, Andre
    LANCET ONCOLOGY, 2013, 14 (06): : 525 - 533
  • [42] Central Nervous System Events In Patients with Diffuse Large B-Cell Lymphoma In the Rituximab Era
    Tomita, Naoto
    Yokoyama, Masahiro
    Yamamoto, Wataru
    Watanabe, Reina
    Shimazu, Yutaka
    Tsunoda, Saburo
    Masaki, Yasufumi
    Hashimoto, Chizuko
    Murayama, Kayoko
    Yano, Takahiro
    Okamoto, Rumiko
    Kikuchi, Ako
    Tamura, Kazuo
    Sato, Kazuya
    Sunami, Kazutaka
    Shibayama, Hirohiko
    Takimoto, Rishu
    Oshima, Rika
    Hatta, Yoshihiro
    Moriuchi, Yoshiyuki
    Kinoshita, Tomohiro
    Yamamoto, Masahide
    Numata, Ayumi
    Ishigatsubo, Yoshiaki
    Takeuchi, Kengo
    BLOOD, 2010, 116 (21) : 1610 - 1610
  • [43] Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era
    Tomita, Naoto
    Yokoyama, Masahiro
    Yamamoto, Wataru
    Watanabe, Reina
    Shimazu, Yutaka
    Masaki, Yasufumi
    Tsunoda, Saburo
    Hashimoto, Chizuko
    Murayama, Kayoko
    Yano, Takahiro
    Okamoto, Rumiko
    Kikuchi, Ako
    Tamura, Kazuo
    Sato, Kazuya
    Sunami, Kazutaka
    Shibayama, Hirohiko
    Takimoto, Rishu
    Ohshima, Rika
    Hatta, Yoshihiro
    Moriuchi, Yukiyoshi
    Kinoshita, Tomohiro
    Yamamoto, Masahide
    Numata, Ayumi
    Ishigatsubo, Yoshiaki
    Takeuchi, Kengo
    CANCER SCIENCE, 2012, 103 (02) : 245 - 251
  • [44] Low Rate of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Despite Limited Use of Intrathecal Prophylaxis
    Aleem, Aamer
    Algahtani, Farjah
    Alzahrani, Musa
    Jamal, Ahmed
    Alsaleh, Khalid
    Sewaralthahab, Sarah
    Alshalati, Fatimah
    Aloraini, Omar
    Almozini, Mohammed
    Abdulkarim, Abdulaziz
    Alayed, Omar
    Alotaibi, Ghazi
    JOURNAL OF HEMATOLOGY, 2025, 14 (01) : 14 - 19
  • [45] A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
    Coiffier, Bertrand
    Thieblemont, Catherine
    de Guibert, Sophie
    Dupuis, Jehan
    Ribrag, Vincent
    Bouabdallah, Reda
    Morschhauser, Franck
    Navarro, Robert
    Le Gouill, Steven
    Haioun, Corinne
    Houot, Roch
    Casasnovas, Olivier
    Holte, Harald
    Lamy, Thierry
    Broussais, Florence
    Payrard, Sandrine
    Hatteville, Laurence
    Tilly, Herve
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (05) : 722 - 730
  • [46] A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era
    Hosein, Peter J.
    Maragulia, Jocelyn C.
    Salzberg, Matthew P.
    Press, Oliver W.
    Habermann, Thomas M.
    Vose, Julie M.
    Bast, Martin
    Advani, Ranjana H.
    Tibshirani, Robert
    Evens, Andrew M.
    Islam, Nahida
    Leonard, John P.
    Martin, Peter
    Zelenetz, Andrew D.
    Lossos, Izidore S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (03) : 358 - 363
  • [47] Phase II open study using Rituximab (MabThera) plus CHOP in treatment of pts with diffuse large B-cell Lymphoma (DLCL)
    Shahrasbi, A.
    Raafat, J.
    Latifzadeh, Z.
    ANNALS OF ONCOLOGY, 2004, 15 : 156 - 156
  • [48] Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
    Woo, Ha Young
    Chae, Seoung Wan
    Do, Sung-Im
    Na, Kiyong
    ANTICANCER RESEARCH, 2022, 42 (11) : 5601 - 5608
  • [49] Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
    Garcia-Reyero, Julia
    Martinez Magunacelaya, Nerea
    Gonzalez Perena, Ainara
    Marcos Gonzalez, Sara
    Teran-Villagra, Nuria
    Azueta, Ainara
    Batlle, Ana
    Gonzalez de Villambrosia, Sonia
    Revert Arce, Jose
    Montes-Moreno, Santiago
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (08) : E68 - E71
  • [50] Primary Diffuse Large B-cell Central Nervous System Lymphoma with Vertigo Presentation
    Hsieh, Tien-Chan
    Karki, Susan
    Kaur, Gagandeep
    West, Jeffrey
    Kloss, Robert
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S18 - S19